At-birth and point-of-care (POC) early infant diagnosis (EID) testing are emerging strategies to streamline infant human immunodeficiency virus (HIV) diagnosis and expedite antiretroviral therapy initiation for HIV-positive infants. Uganda rolled out EID point of care testing in 2018 using Mpima/AlereQ and GeneXpert in 115 sites to ensure services are brought closer to the communities and enable early identification of HIV-infected infants leading to timely initiation to treatment and care

The purpose of this study was to evaluate the early infant diagnosis point of care program against the set targets to provide programmatic information and evidence of the effect of EID POC implementation.
